Bubs to retain full ownership of Bubs® brand intellectual property and the proprietary Bubs® China formulations, specifically formulated for Chinese babies, targeting lower-tier cities.
Ann: MOU to Manufacture SAMR Infant Formula in China, page-51
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.8¢ |
Change
-0.003(2.08%) |
Mkt cap ! $107.0M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.5¢ | 11.8¢ | $664.4K | 5.530M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 1927984 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 165025 | 8 |
View Market Depth
| Last trade - 14.51pm 06/08/2024 (20 minute delay) ? |
| BUB (ASX) Chart |